| [1] |
冯红萍,刘彦威,王婉,等.核苷类似物治疗慢性乙型肝炎HBsAg和HBeAg定量检测的临床意义.肝脏,2013,18:833-835.
|
| [2] |
梁家隐,董慧敏,黄凡华,等.乙型肝炎表面抗原与乙型肝炎e抗原定量对核苷类似物治疗慢性乙肝效果的预测.中国卫生检验杂志, 2017,27:1454:1456.
|
| [3] |
中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版).肝脏,2011,16:2-16.
|
| [4] |
Locamini S,Bowden S.Hepatitis B surface antigen quantification not what it seems on the surface. Hepatology,2012,56:411-414.
|
| [5] |
Larsson SB,Eilard A,Malmstrom S,et al .HBsAg quantification for identification of liver disease in chronic Hepatitis B virus carriers. Liver Int,2014,34:e238-e245.
|
| [6] |
余雪平,郭如意,柯绍鹏,等.慢性乙型肝炎及其肝硬化患者HBsAg和HBV DNA定量变化及其相关性.南方医科大学学报,2015,35:682-686.
|
| [7] |
洪江,刘娟.慢性乙肝合并肝硬化患者血清谷丙转氨酶、乙肝表面抗原水平与肝功能的相关性.上海医药,2015,36:47-49.
|
| [8] |
Zheng XY,Wei RB,Tang L,et al .Meta-analysis of combined therapy for adult Hepatitis B virus-associated glomerulone-phritis. World J Gastroenterol,2012,18:821-832.
|
| [9] |
董爱爱, 赵洁, 贾建伟,等.HBsAg定量检测在慢性HBV感染患者肝脏储备功能评价中的作用.世界华人消化杂志, 2012,20:3033-3036.
|
| [10] |
Jaroszewicz J, Calle Serrano B, Wurthorn K,et al.Hepatitis B surface antigien(HBsAg) levels in the natural history of Hepatitis B virus (HBV infection : a European perspective .Hepatology,2010,52:514-522.
|
| [11] |
孙凤丹,陆许贞,谢新生,等.慢性乙型肝炎及肝硬化患者乙型肝炎表面抗原及乙型肝炎病毒DNA定量检测的临床意义.中华危重症医学杂志,2017,10:172-175.
|
| [12] |
裴颜祯,韩涛,马晓艳,等.HBsAg及HBV DNA定量水平在慢性乙型肝炎、肝硬化和肝癌患者中的变化.中华肝脏病杂志,2011,19:743-746.
|
| [13] |
Wong DK,Yuen MF,Poon RT,et al .Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma. J Hepatol,2006,45:553-559.
|
| [14] |
Wu ZB,Cao H,Liu T,et al .Dynamic expression profile of HBsAg according to hepatitis parenchyma cells’volume at different liver fibrosis stages in the immune clearance phase. Zhonghua Gan Zang Bing Za Zhi,2012,20:742-745.
|
| [15] |
杨美荣,孟冬梅,方正亚,乙型肝炎后肝硬化并发原发性肝癌患者乙型肝炎病毒定量检测的临床意义.中国现代医学杂志,2019,29:76-79.
|
